Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Daruwala Paul Create: Alert

All | News | Filings
Date FiledTypeDescription
09/13/2022 4 Daruwala Paul (COO) has filed a Form 4 on Cidara Therapeutics, Inc.
Txns: Sold 16,199 shares @ $0.6849, valued at $11.1k
04/04/2022 4 Daruwala Paul (COO) has filed a Form 4 on Cidara Therapeutics, Inc.
Txns: Granted 50,000 shares @ $0
Granted 100,000 options to buy @ $0.83, valued at $83k
01/07/2022 4 Daruwala Paul (COO) has filed a Form 4 on Cidara Therapeutics, Inc.
Txns: Sold 5,133 shares @ $1.25, valued at $6.4k
Exercised 5,000 restricted stock units @ $0
Exercised 4,900 restricted stock units @ $0
10/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/25/2020 4/A Daruwala Paul (COO) has filed a Form 4 on Cidara Therapeutics, Inc.
Txns: Sold 940 shares @ $3.42, valued at $3.2k
03/23/2020 4 Daruwala Paul (COO) has filed a Form 4 on Cidara Therapeutics, Inc.
Txns: Granted 90,000 options to buy @ $1.98, valued at $178.2k
01/06/2020 4 Daruwala Paul (COO) has filed a Form 4 on Cidara Therapeutics, Inc.
Txns: Sold 2,340 shares @ $3.42, valued at $8k
12/20/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/03/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/16/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/22/2019 4 Daruwala Paul (COO) has filed a Form 4 on Cidara Therapeutics, Inc.
Txns: Granted 77,000 options to buy @ $2.61, valued at $201k
03/08/2019 4 Daruwala Paul (COO) has filed a Form 4 on Cidara Therapeutics, Inc.
Txns: Sold 2,240 shares @ $2.5507, valued at $5.7k
02/01/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/02/2018 4 Daruwala Paul (COO) has filed a Form 4 on Cidara Therapeutics, Inc.
Txns: Granted 72,000 options to buy @ $4, valued at $288k
09/19/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/04/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
03/18/2016 4 Daruwala Paul (Chief Commercial Officer) has filed a Form 4 on Cidara Therapeutics, Inc.
Txns: Granted 50,000 options to buy @ $9.89, valued at $494.5k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy